Russell Investments Group Ltd. Buys Shares of 93,900 Revvity, Inc. (NYSE:RVTY)

Russell Investments Group Ltd. acquired a new stake in shares of Revvity, Inc. (NYSE:RVTY - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 93,900 shares of the company's stock, valued at approximately $10,291,000. Russell Investments Group Ltd. owned approximately 0.08% of Revvity as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of the stock. Truist Financial Corp acquired a new stake in Revvity in the fourth quarter valued at approximately $7,089,000. Prentiss Smith & Co. Inc. purchased a new stake in Revvity during the 4th quarter worth approximately $220,000. State of New Jersey Common Pension Fund D purchased a new stake in shares of Revvity during the fourth quarter valued at $7,832,000. Tokio Marine Asset Management Co. Ltd. acquired a new position in shares of Revvity in the fourth quarter valued at about $411,000. Finally, Bfsg LLC acquired a new stake in shares of Revvity during the fourth quarter worth about $791,000. Hedge funds and other institutional investors own 86.65% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts have commented on RVTY shares. TD Cowen lifted their price objective on shares of Revvity from $123.00 to $130.00 and gave the company a "buy" rating in a research note on Tuesday, April 30th. Raymond James upped their target price on Revvity from $106.00 to $127.00 and gave the stock an "outperform" rating in a research note on Friday, February 2nd. UBS Group downgraded Revvity from a "buy" rating to a "neutral" rating and boosted their price target for the company from $105.00 to $125.00 in a report on Tuesday, January 16th. Robert W. Baird lifted their target price on shares of Revvity from $126.00 to $127.00 and gave the company an "outperform" rating in a report on Tuesday, April 30th. Finally, Barclays raised their price target on shares of Revvity from $92.00 to $105.00 and gave the company an "equal weight" rating in a research report on Thursday, January 25th. Six investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, Revvity presently has an average rating of "Moderate Buy" and a consensus target price of $118.17.

Revvity Trading Up 2.2 %

Shares of Revvity stock traded up $2.21 on Monday, reaching $102.82. The company had a trading volume of 898,128 shares, compared to its average volume of 848,764. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.92 and a current ratio of 2.23. The firm has a market cap of $12.70 billion, a PE ratio of 83.15, a PEG ratio of 2.62 and a beta of 1.09. The firm's 50 day moving average price is $104.56 and its two-hundred day moving average price is $101.25. Revvity, Inc. has a 52-week low of $79.50 and a 52-week high of $131.96.

Revvity (NYSE:RVTY - Get Free Report) last posted its quarterly earnings data on Monday, April 29th. The company reported $0.98 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.94 by $0.04. The firm had revenue of $649.90 million for the quarter, compared to the consensus estimate of $646.83 million. Revvity had a return on equity of 7.37% and a net margin of 5.49%. The company's quarterly revenue was down 3.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.01 EPS. Sell-side analysts predict that Revvity, Inc. will post 4.66 earnings per share for the current fiscal year.

Revvity Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 9th. Shareholders of record on Friday, July 19th will be given a $0.07 dividend. The ex-dividend date of this dividend is Friday, July 19th. This represents a $0.28 annualized dividend and a yield of 0.27%. Revvity's dividend payout ratio is presently 23.14%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.